Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
Sponsor: University of Sao Paulo
Summary
This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy. Clinical and subclinical signs of disease activity added with electroretinogram exams, through predefined intervals, will be evaluated through a minimum 12-month follow-up.
Official title: Influência de imunomodulação Precoce Influence of Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease: a Prospective Study
Key Details
Gender
All
Age Range
10 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2015-03-23
Completion Date
2028-12
Last Updated
2026-05-07
Healthy Volunteers
No
Conditions
Interventions
Early high-dose corticosteroid and immunosuppressive therapy
Early high-dose corticosteroid and immunosuppressive therapy
Locations (1)
Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo
São Paulo, São Paulo, Brazil